Cedars-Sinai Releases Three Free Agentic AI Tools
The publicly available software tools are named ASAREE, Memstara and GENASYS and are aimed at biomedical research.
Updated on Nov. 9, 2026 in Artificial Intelligence

Live Poll
Do you trust AI tools used in medical research to produce reliable results?
Cedars-Sinai has released three free, publicly available software tools for building, modifying and monitoring agentic AI systems used in biomedical research. The tools, named ASAREE, Memstara and GENASYS, are available online at no cost.
Why it matters
Commercial agentic AI systems often lack transparency, which raises concerns about the reliability of their results. Public access to these tools lets outside users test, adapt and contribute improvement ideas to the systems.
Cedars-Sinai released three free agentic AI software packages, the source of the figure being the institution's own announcement. The extraction does not report performance benchmarks for the tools, and their real-world effectiveness remains unverified.
The players
Cedars-Sinai
Cedars-Sinai is a Los Angeles-based health system and academic medical center that developed the three publicly available agentic AI tools.
The details
ASAREE lets researchers test hypotheses about AI workflows by evaluating different approaches, while Memstara uses knowledge about relationships among genes, diseases and biomarkers to generate biological hypotheses. GENASYS automatically modifies agentic AI workflows, evaluates alternative configurations and selects the best-performing ones for a biomedical task.
Timeline
Nov. 9, 2026: Cedars-Sinai announced the three software tools.
The Tech Race
The release places open, inspectable agentic AI tooling in biomedical research against commercial systems that often keep their workings opaque. It positions a health research institution as a public contributor to the agentic AI field rather than only a user of commercial platforms.
Researchers and developers can download and use ASAREE, Memstara and GENASYS without cost to test or modify agentic AI workflows. Patients and clinicians will not see direct changes from this release, as the tools are aimed at research rather than clinical care.
The takeaway
Publicly available AI tools let outside researchers check and improve how agentic systems work instead of relying only on closed commercial products. Readers following AI in healthcare can watch whether outside users adopt these tools and report results.
Further reading
For broader context on how these systems are being built and shared, explore Artificial Intelligence coverage on Wisevoter.
Source note: This article includes information reported by Becker's Hospital Review | Healthcare News & Analysis.
Live Poll
Do you trust AI tools used in medical research to produce reliable results?






